BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 20947496)

  • 1. GPRC6A mediates the non-genomic effects of steroids.
    Pi M; Parrill AL; Quarles LD
    J Biol Chem; 2010 Dec; 285(51):39953-64. PubMed ID: 20947496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells.
    Ye R; Pi M; Nooh MM; Bahout SW; Quarles LD
    Mol Pharmacol; 2019 May; 95(5):563-572. PubMed ID: 30894404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and Functional Evidence for Testosterone Activation of GPRC6A in Peripheral Tissues.
    Pi M; Kapoor K; Wu Y; Ye R; Senogles SE; Nishimoto SK; Hwang DJ; Miller DD; Narayanan R; Smith JC; Baudry J; Quarles LD
    Mol Endocrinol; 2015 Dec; 29(12):1759-73. PubMed ID: 26440882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPRC6A regulates prostate cancer progression.
    Pi M; Quarles LD
    Prostate; 2012 Mar; 72(4):399-409. PubMed ID: 21681779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired osteoblast function in GPRC6A null mice.
    Pi M; Zhang L; Lei SF; Huang MZ; Zhu W; Zhang J; Shen H; Deng HW; Quarles LD
    J Bone Miner Res; 2010 May; 25(5):1092-102. PubMed ID: 19874200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.
    Ye R; Pi M; Cox JV; Nishimoto SK; Quarles LD
    J Exp Clin Cancer Res; 2017 Jun; 36(1):90. PubMed ID: 28659174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo.
    Pi M; Wu Y; Quarles LD
    J Bone Miner Res; 2011 Jul; 26(7):1680-3. PubMed ID: 21425331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks.
    Pi M; Quarles LD
    Endocrinology; 2012 May; 153(5):2062-9. PubMed ID: 22374969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPCR6A Is a Molecular Target for the Natural Products Gallate and EGCG in Green Tea.
    Pi M; Kapoor K; Ye R; Smith JC; Baudry J; Quarles LD
    Mol Nutr Food Res; 2018 Apr; 62(8):e1700770. PubMed ID: 29468843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome.
    Pi M; Chen L; Huang MZ; Zhu W; Ringhofer B; Luo J; Christenson L; Li B; Zhang J; Jackson PD; Faber P; Brunden KR; Harrington JJ; Quarles LD
    PLoS One; 2008; 3(12):e3858. PubMed ID: 19050760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of the GPRC6A receptor signaling pathways using a mammalian cell line stably expressing the receptor.
    Jacobsen SE; Nørskov-Lauritsen L; Thomsen AR; Smajilovic S; Wellendorph P; Larsson NH; Lehmann A; Bhatia VK; Bräuner-Osborne H
    J Pharmacol Exp Ther; 2013 Nov; 347(2):298-309. PubMed ID: 24008333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine GPRC6A Mediates Cellular Responses to L-Amino Acids, but Not Osteocalcin Variants.
    Rueda P; Harley E; Lu Y; Stewart GD; Fabb S; Diepenhorst N; Cremers B; Rouillon MH; Wehrle I; Geant A; Lamarche G; Leach K; Charman WN; Christopoulos A; Summers RJ; Sexton PM; Langmead CJ
    PLoS One; 2016; 11(1):e0146846. PubMed ID: 26785252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPRC6A: Jack of all metabolism (or master of none).
    Pi M; Nishimoto SK; Quarles LD
    Mol Metab; 2017 Feb; 6(2):185-193. PubMed ID: 28180060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Explaining Divergent Observations Regarding Osteocalcin/GPRC6A Endocrine Signaling.
    Pi M; Nishimoto SK; Darryl Quarles L
    Endocrinology; 2021 Apr; 162(4):. PubMed ID: 33474566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel extracellular cation-sensing G-protein-coupled receptor.
    Pi M; Faber P; Ekema G; Jackson PD; Ting A; Wang N; Fontilla-Poole M; Mays RW; Brunden KR; Harrington JJ; Quarles LD
    J Biol Chem; 2005 Dec; 280(48):40201-9. PubMed ID: 16199532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology and physiological function of the orphan GPRC6A receptor.
    Jørgensen CV; Bräuner-Osborne H
    Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6():77-87. PubMed ID: 32056382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocyte-specific GPRC6A ablation promotes diet-induced obesity by inhibiting lipolysis.
    Mukai S; Mizokami A; Otani T; Sano T; Matsuda M; Chishaki S; Gao J; Kawakubo-Yasukochi T; Tang R; Kanematsu T; Takeuchi H; Jimi E; Hirata M
    J Biol Chem; 2021; 296():100274. PubMed ID: 33428938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane Androgen Receptors Unrelated to Nuclear Steroid Receptors.
    Thomas P
    Endocrinology; 2019 Apr; 160(4):772-781. PubMed ID: 30753403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for Osteocalcin Binding and Activation of GPRC6A in β-Cells.
    Pi M; Kapoor K; Ye R; Nishimoto SK; Smith JC; Baudry J; Quarles LD
    Endocrinology; 2016 May; 157(5):1866-80. PubMed ID: 27007074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function.
    Clemmensen C; Smajilovic S; Wellendorph P; Bräuner-Osborne H
    Br J Pharmacol; 2014 Mar; 171(5):1129-41. PubMed ID: 24032653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.